What is the level of liabilities of SI-BONE this year?
SI-BONE has a debt balance of 61.05 M USD this year.
SI-BONE Liabilities 2024
SI-BONE Liabilities
61.05 M USD
Ticker
SIBN
ISIN
US8257041090
WKN
A2N7LY
In 2024, SI-BONE's total liabilities amounted to 61.05 M USD, a 2.95% difference from the 59.3 M USD total liabilities in the previous year.
SI-BONE Aktienanalyse
What does SI-BONE do?
SI-BONE Inc. is an innovative medical technology company based in Santa Clara, California. It was founded in 2008 by a group of orthopedic surgeons, engineers, and entrepreneurs who aimed to improve the treatment of lower back pain. The company is now globally recognized and specializes in the development and marketing of implants for the treatment of pain and discomfort in the pelvic and back areas. SI-BONE focuses on the treatment of pain and discomfort in the pelvic and back areas, offering a range of products for this purpose. The company's main focus is on the development of innovative implants that can be used minimally invasively, with the goal of providing patients with quick recovery and improved quality of life. The flagship product of SI-BONE is the iFuse implant. This implant is used in patients with chronic lower back pain caused by instability of the spine or pelvis. The iFuse implant stabilizes the pelvis and thereby reduces the pain originating from the unstable joint region. The iFuse implant has been FDA approved and is now available in over 40 countries worldwide. In addition to the iFuse implant, SI-BONE also offers a variety of other products tailored to the needs of physicians and patients. These include implantable instruments and consumables such as bone screws or arthroscopy needles. SI-BONE is a publicly traded company listed on NASDAQ under the ticker symbol "SIBN." The company's business model is based on providing innovative products to physicians and hospitals that optimize the treatment of back pain. To achieve this, SI-BONE works closely with leading industry professionals to enable optimal treatment of back pain. SI-BONE has established itself as a strong, innovative company specializing in minimally invasive implants in the field of pain therapy. Through close collaboration with physicians and specialists and investment in research and development of cutting-edge technologies, SI-BONE aims to continue growing and achieve a leading position in the field of pain therapy. SI-BONE ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing SI-BONE's Liabilities
SI-BONE's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating SI-BONE's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing SI-BONE's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
SI-BONE's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in SI-BONE’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about SI-BONE stock
What were the liabilities of SI-BONE compared to the previous year?
The liabilities of SI-BONE have increased by 2.95% increased compared to the previous year.
What are the consequences of high debt for investors of SI-BONE?
High liabilities can pose a risk for investors of SI-BONE, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in SI-BONE?
Low liabilities mean that SI-BONE has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of SI-BONE affect the company?
An increase in liabilities of SI-BONE can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of SI-BONE affect the company?
A decrease in the liabilities of SI-BONE can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of SI-BONE?
Some factors that can influence the liabilities of SI-BONE include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of SI-BONE so important for investors?
The liabilities of SI-BONE are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can SI-BONE take to modify the liabilities?
To change its liabilities, SI-BONE can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does SI-BONE pay?
Over the past 12 months, SI-BONE paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, SI-BONE is expected to pay a dividend of 0 USD.
What is the dividend yield of SI-BONE?
The current dividend yield of SI-BONE is .
When does SI-BONE pay dividends?
SI-BONE pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of SI-BONE?
SI-BONE paid dividends every year for the past 0 years.
What is the dividend of SI-BONE?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is SI-BONE located?
SI-BONE is assigned to the 'Health' sector.
Wann musste ich die Aktien von SI-BONE kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of SI-BONE from 7/7/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/7/2024.
When did SI-BONE pay the last dividend?
The last dividend was paid out on 7/7/2024.
What was the dividend of SI-BONE in the year 2023?
In the year 2023, SI-BONE distributed 0 USD as dividends.
In which currency does SI-BONE pay out the dividend?
The dividends of SI-BONE are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The SI-BONE stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von SI-BONE
Our stock analysis for SI-BONE Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SI-BONE Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
